Best Kinase Inhibitor for myelodysplastic-myeloproliferative diseases
2 Kinase Inhibitor drugs indicated for myelodysplastic-myeloproliferative diseases, ranked by our independent rating. The current highest-rated is gleevec. Compare them with all treatments for myelodysplastic-myeloproliferative diseases or the full Kinase Inhibitor class. Not medical advice — always consult a professional.
Top kinase inhibitor for myelodysplastic-myeloproliferative diseases: 1. Gleevec · 2. Imkeldi
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Gleevec | 68/100 | Prescription | $26 | View → |
| 2 | Imkeldi | Not yet rated | Prescription | $26 | View → |
Full ranking · 2 drugs
Frequently asked
- What is the best kinase inhibitor for myelodysplastic-myeloproliferative diseases?
- By our independent rating, gleevec currently ranks highest among Kinase Inhibitor drugs used for myelodysplastic-myeloproliferative diseases. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which kinase inhibitor drugs treat myelodysplastic-myeloproliferative diseases?
- pharmaranks lists 2 Kinase Inhibitor products indicated for myelodysplastic-myeloproliferative diseases, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.